Status:

UNKNOWN

Aspirin Discontinuation After Left Atrial Appendage Occlusion in Atrial Fibrillation

Lead Sponsor:

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Conditions:

Atrial Fibrillation

Stroke

Eligibility:

All Genders

18-90 years

Phase:

NA

Brief Summary

The ASPIRIN LAAO trial is a prospective, multi-center, randomized, double blinded, placebo-controlled study aiming at investigating the safety of terminating the use of aspirin after left atrial appen...

Detailed Description

The ASPIRIN LAAO trial is a prospective, multi-center, randomized, double blinded, placebo-controlled study aiming at investigating the safety of terminating the use of aspirin since the sixth month a...

Eligibility Criteria

Inclusion

  • Age between 18 and 90 years
  • Paroxysmal, persistent, long-standing persistent or permanent nonvalvular AF
  • Have already had a Watchman LAAO device implanted 6 months ago

Exclusion

  • Clinical Exclusion Criteria
  • Long-term aspirin therapy required
  • Including coronary artery disease, symptomatic carotid disease, prior myocardial infarction, strokes or systemic embolism, etc
  • Contraindicated for aspirin therapy
  • Including active peptic ulcer, thrombocytopenia or anemia, etc.
  • Uncontrolled malignant tumor
  • Abnormal liver, renal or coagulation function
  • Pregnant or pregnancy is planned during the course of the investigation
  • Terminal illness with life expectancy \<1 year
  • Enrolled in another IDE or IND investigation of a cardiovascular device or an investigational drug
  • TEE Exclusion Criteria\*
  • Peri-device leak \>5mm
  • Device-related thrombus
  • Other intracardiac thrombus

Key Trial Info

Start Date :

June 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2024

Estimated Enrollment :

1120 Patients enrolled

Trial Details

Trial ID

NCT03821883

Start Date

June 1 2020

End Date

December 1 2024

Last Update

October 12 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Xinhua Hospital, School of Medicne, Shanghai Jiao Tong University

Shanghai, Shanghai Municipality, China, 200092